AusCann Group Holdings has confirmed a $12 million capital raising to fund the development and manufacture of medical cannabis products in Australia.
AusCann raises $12m
19/05/2017 - 13:33
Related Data & Insights
-
AusCann Group HoldingsClosing price for the last 90 trading daysPowered by Morningstar ®
-
Rank Company Revenue 154th AusCann Group Holdings $1.7m 155th Zelira Therapeutics $1.6m 156th One Click Group $1.6m 158th InteliCare $1.5m 159th Norwood Systems $1.5m 200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Related Articles
01 Dec 2023
Board Moves December 1, 2023
29 Jun 2023
Board Moves June 29, 2023
03 Jan 2023
Board Moves January 3, 2023
13 Sep 2022
Board Moves September 13, 2022
13 Sep 2022
AusCann chief executive resigns
09 Sep 2022
AusCann updates on European deal, property sale
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX